NCT05411952

Brief Summary

Type 1 Diabetes Mellitus (T1DM) is a heterogeneous condition and is an absolute insulin deficiency resulting from autoimmune-mediated destruction of pancreatic β-cells (1). The incidence of T1DM has been increasing globally since the 1950s, particularly in children, with an average annual increase of 3-4% over the past three decades.Despite the advances in medical treatment and technology, nutritional therapy continues to be the main component of diabetes treatment. Medical nutrition further improves metabolic control outcomes when T1DM care is combined with other treatments.This study was conducted to examine the effect of family-based behavioral medical nutrition therapy training on nutritional status and metabolic control in children and adolescents with Type 1 diabetes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 13, 2020

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 28, 2021

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2021

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

May 30, 2022

Completed
10 days until next milestone

First Posted

Study publicly available on registry

June 9, 2022

Completed
Last Updated

June 9, 2022

Status Verified

June 1, 2022

Enrollment Period

6 months

First QC Date

May 30, 2022

Last Update Submit

June 6, 2022

Conditions

Keywords

Type 1 diabetes, nutrition education, metabolic control

Outcome Measures

Primary Outcomes (1)

  • Change in mean of HbA1c from baseline to 6 months

    All data were analysed by using IBM SPSS Statistics 26 and significance was defined as p\< 0.05

    6 months

Secondary Outcomes (2)

  • Change in mean of Healthy Eating Index 2015 (HEI-2015) score from baseline to 6 Months

    6 months

  • Change in mean of Mediterranean Diet Quality Index Scale (KIDMED) from baseline to 6 Months

    6 months

Study Arms (3)

education-mother and child dyad

EXPERIMENTAL

Mother and child dyad have received dietary intervention for 6 months

Other: Medical nutrition therapy and carbohydrate counting education

education-only child

EXPERIMENTAL

Children have received dietary intervention for 6 months. But their mothers didn't receive any dietary intervention

Other: Medical nutrition therapy and carbohydrate counting education

control

EXPERIMENTAL

Control group did't receive any dietary intervention during the study

Other: No intervention

Interventions

Children and their mothers have received family-based behavioral medical nutrition therapy and carbohydrate counting education for 6 months by trained dietitian

education-mother and child dyad

Control group didn't receive any intervention by trained dietitian. Furthermore they continued their routine health controls.

control

Eligibility Criteria

Age8 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • years old,
  • Being diagnosed with T1DM for at least ≥1 year, maximum ≤5 years,
  • Latest HbA1c ≥6.5% - \<13.5%,
  • Receiving intensive insulin therapy (at least 3 times a day bolus and 1 time basal insulin administration or using an insulin pump),
  • No communication problems
  • Children and adolescents without any other disease accompanying diabetes were included in the study.

You may not qualify if:

  • Celiac, cystic fibrosis etc. with gastrointestinal diseases,
  • Using any drug that may affect glucose metabolism,
  • Switched from an insulin pen to an insulin pump in less than 6 months,
  • Involved in any other intervention work in the last 6 months,
  • and individuals with communication problems were not included in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gaziantep Cengiz Gokcek Gynecology and Pediatrics Hospital

Gaziantep, 27010, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 1

Interventions

Nutrition Therapy

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System Diseases

Intervention Hierarchy (Ancestors)

Therapeutics

Study Officials

  • Gulden KOKSAL, Prof.

    Hasan Kalyoncu University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The sample of the study was consisted of 75 (male= 36, female= 39) children and adolescents in total, including Intervention 1 group (n=25), Intervention 2 (n=25) group and Control (n=25) group determined by double-blind, stratified, random method.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant

Study Record Dates

First Submitted

May 30, 2022

First Posted

June 9, 2022

Study Start

August 13, 2020

Primary Completion

January 28, 2021

Study Completion

September 15, 2021

Last Updated

June 9, 2022

Record last verified: 2022-06

Data Sharing

IPD Sharing
Will not share

Locations